Atosiban (atosiban): Reviews and patient testimonials

Atosiban 37.5 mg/5 ml concentrate for solution for infusion

Atosiban is indicated to delay imminent pre-term birth in pregnant adult women with:

- regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes

- a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%

- a gestational age from 24 until 33 completed weeks

- a normal foetal heart rate

Atosiban 37.5mg/5ml concentrate for solution for infusion vials

Atosiban is indicated to delay imminent pre-term birth in pregnant adult women with:

− regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes

− a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%

− a gestational age from 24 until 33 completed weeks

− a normal foetal heart rate

Atosiban 6.75mg/0.9ml solution for injection ampoules

Atosiban is indicated to delay imminent pre-term birth in pregnant adult women with:

− regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes

− a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%

− a gestational age from 24 until 33 completed weeks

− a normal foetal heart rate

Atosiban Accord 37.5 mg/5 ml concentrate for solution for infusion

Atosiban accord injection is indicated to delay imminent pre-term birth in pregnant adult women with:

- regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes

- a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%

- a gestational age from 24 until 33 completed weeks

- a normal foetal heart rate

Route of administration: Injectable
Molecule: atosiban